NCT06313437 2026-03-25Revumenib in Combination With 7+3 + Midostaurin in AMLDana-Farber Cancer InstitutePhase 1 Recruiting22 enrolled
NCT00651261 2021-08-18Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaAlliance for Clinical Trials in OncologyPhase 3 Unknown717 enrolled 14 charts
NCT01202877 2018-10-16PKC412 and 5-AzacytidineM.D. Anderson Cancer CenterPhase 1/2 Completed54 enrolled 8 charts